| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $25K | -74.9% | +111.6% |
| SG&A Expense | $17K | -5.3% | -0.4% |
| Operating Income | -$123K | +38.6% | -32.3% |
| Interest Expense | $24K | +13.8% | +145.4% |
| Pre-tax Income | -$144K | +22.4% | -58.9% |
| Income Tax | $0 | — | — |
| Net Income | -$144K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6K | — | — |
| Current Assets | $6K | +26.9% | -96.7% |
| Total Assets | $6K | +26.9% | -96.7% |
| Current Liabilities | $3.4M | +4.5% | +13.9% |
| Total Liabilities | $3.4M | +4.5% | +13.9% |
| Stockholders' Equity | -$3.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$115K | +2.5% | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $100K | +0.4% | — |
| -58.9% |
| EPS (Diluted) | $0.00 | — | — |
| -4.5% |
| -20.5% |